Mental Health Bulletin, July 2008



[pic]

This bulletin covers aspects of head and neck cancers and should be of interest to multidisciplinary teams working in this area.

Sections can include:

• Combined Modality Therapies

• Drug Therapy

• Pathology, Staging, Polymorphisms & Biomarkers

• Prognosis, Survival & Risk Factors

• Radiotherapy & Imaging

• Supportive Care & Symptom Management

• Surgery

Many of the following articles are available online via the NHS Scotland Knowledge Network. Please use the links where provided and your ATHENS password. A complete list of available online journals and registration for ATHENS can be found at knowledge.scot.nhs.uk/

If the article you require is not available via the NHS Scotland Knowledge Network and you would like to request a print copy, please submit your request online at gglss.scot.nhs.uk

This bulletin contains a selection of material gathered from a search of the evidence base, and is not intended to be comprehensive. Professional judgment should be exercised when appraising the material. The Library takes no responsibility for the wording, content and accuracy of the information supplied, which has been extracted in good faith from reputable sources. NHSGGC is not responsible for the content of external internet sites.

Compiled by:

Kirsty Coltart

Specialist Librarian

Beatson West of Scotland Cancer Centre

0141 301 7285, kirsty.coltart@ggc.scot.nhs.uk

Combined Modality Therapies

Chan AT. Nasopharyngeal carcinoma. Annals of Oncology. 21 Suppl 7:vii308-vii312, 2010 Oct.

Chen SW. Yang SN. Liang JA. The outcome and prognostic factors in patients with aspiration pneumonia during concurrent chemoradiotherapy for head and neck cancer. European Journal of Cancer Care. 19(5):631-5, 2010 Sep.

Crozier E. Sumer BD. Head and neck cancer. Medical Clinics of North America. 94(5):1031-46, 2010 Sep.

Genden EM. Ferlito A. Silver CE. Contemporary management of cancer of the oral cavity. European Archives of Oto-Rhino-Laryngology. 267(7):1001-17, 2010 Jul.

Lee AW. Tung SY. Chua DT. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma. Journal of the National Cancer Institute. 102(15):1188-98, 2010 Aug 4.

Lu H. Chen J. Huang B. Feasibility and efficacy study of weekly cisplatin with concurrent intensity-modulated radiation therapy for nasopharyngeal carcinoma: preliminary results. Oral Oncology. 46(10):743-7, 2010 Oct.

Paccagnella A. Ghi MG. Loreggian L. Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study. Annals of Oncology. 21(7):1515-22, 2010 Jul.

Posner MR. Integrating systemic agents into multimodality treatment of locally advanced head and neck cancer. Annals of Oncology. 21 Suppl 7:vii246-vii251, 2010 Oct.

Shueng PW. Wu LJ. Chen SY. Concurrent chemoradiotherapy with helical tomotherapy for oropharyngeal cancer: a preliminary result. International Journal of Radiation Oncology, Biology, Physics. 77(3):715-21, 2010 Jul 1.

Smee RI. Meagher NS. Broadley K. Recurrent nasopharyngeal carcinoma: current management approaches. American Journal of Clinical Oncology. 33(5):469-73, 2010 Oct.

Tham IW. Lu JJ. Controversies and challenges in the current management of nasopharyngeal cancer. Expert Review of Anticancer Therapy. 10(9):1439-50, 2010 Sep.

Tsukuda M. Ishitoya J. Matsuda H. Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck. Cancer Chemotherapy & Pharmacology. 66(4):729-36, 2010 Sep.

Vermorken JB. Specenier P. Optimal treatment for recurrent/metastatic head and neck cancer.

Annals of Oncology. 21 Suppl 7:vii252-vii261, 2010 Oct.

Weinstein GS. Quon H. O'Malley BW Jr. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial. Laryngoscope. 120(9):1749-55, 2010 Sep.

Drug Therapy

Bourhis J. Lefebvre JL. Vermorken JB. Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options?. European Journal of Cancer. 46(11):1979-89, 2010 Jul.

Divi V. Worden FP. Prince ME. Chemotherapy alone for organ preservation in advanced laryngeal cancer. Head & Neck. 32(8):1040-7, 2010 Aug.

Furness S. Glenny AM. Worthington HV. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. Cochrane Database of Systematic Reviews. 9:CD006386, 2010.

Halfdanarson TR. Jatoi A. Oral cancer chemotherapy: the critical interplay between patient education and patient safety. Current Oncology Reports. 12(4):247-52, 2010 Jul.

Williamson SK. Moon J. Huang CH. Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420. Journal of Clinical Oncology. 28(20):3330-5, 2010 Jul 10.

Pathology, Staging, Polymorphisms & Biomarkers

Allen CT. Lewis JS Jr. El-Mofty SK. Human papillomavirus and oropharynx cancer: biology, detection and clinical implications. Laryngoscope. 120(9):1756-72, 2010 Sep.

Chapireau D. Adlam D. Cameron M. Paraneoplastic syndromes in patients with primary oral cancers: a systematic review. British Journal of Oral & Maxillofacial Surgery. 48(5):338-44, 2010 Jul.

Chapman DB. Lippert D. Geer CP. Clinical, histopathologic, and radiographic indicators of malignancy in head and neck paragangliomas. Otolaryngology - Head & Neck Surgery. 143(4):531-7, 2010 Oct.

Colella G. Cannavale R. Flamminio F. Fine-needle aspiration cytology of salivary gland lesions: a systematic review. Journal of Oral & Maxillofacial Surgery. 68(9):2146-53, 2010 Sep.

Evans M. Powell NG. The changing aetiology of head and neck cancer: the role of human papillomavirus. Clinical Oncology (Royal College of Radiologists). 22(7):538-46, 2010 Sep.

Shuman AG. Entezami P. Chernin AS. Demographics and efficacy of head and neck cancer screening. Otolaryngology - Head & Neck Surgery. 143(3):353-60, 2010 Sep.

Stauber RH. Wunsch D. Knauer SK. An update on the pathobiological relevance of nuclear receptors for cancers of the head and neck.. Histology & Histopathology. 25(8):1093-104, 2010 Aug.

Prognosis, Survival & Risk Factors

Ang KK. Harris J. Wheeler R. Human papillomavirus and survival of patients with oropharyngeal cancer. New England Journal of Medicine. 363(1):24-35, 2010 Jul 1.

Bower WF. Vlantis AC. Chung TM. Mode of treatment affects quality of life in head and neck cancer survivors: Implications for holistic care. Acta Oto-Laryngologica. 130(10):1185-92, 2010 Oct.

Gao F. Wee J. Wong HB. Quality-of-life-adjusted survival analysis of concurrent chemo radiotherapy for locally advanced (nonmetastatic) nasopharyngeal cancer. International Journal of Radiation Oncology, Biology, Physics. 78(2):454-60, 2010 Oct 1.

Hessel AC. Moreno MA. Hanna EY. Compliance with quality assurance measures in patients treated for early oral tongue cancer. Cancer. 116(14):3408-16, 2010 Jul 15.

Mallik S. Agarwal J. Gupta T. Prognostic factors and outcome analysis of submandibular gland cancer: a clinical audit. Journal of Oral & Maxillofacial Surgery. 68(9):2104-10, 2010 Sep.

Marur S. D'Souza G. Westra WH. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncology. 11(8):781-9, 2010 Aug.

Paleri V. Wight RG. Silver CE. Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice. Oral Oncology. 46(10):712-9, 2010 Oct.

Papadas TA. Alexopoulos EC. Mallis A .Survival after laryngectomy: a review of 133 patients with laryngeal carcinoma. European Archives of Oto-Rhino-Laryngology. 267(7):1095-101, 2010 Jul.

Rischin D. Young RJ. Fisher R. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. Journal of Clinical Oncology. 28(27):4142-8, 2010 Sep 20.

Wang TC. Hua CH. Lin CC. Risk factors affect the survival outcome of hard palatal and maxillary alveolus squamous cell carcinoma: 10-year review in a tertiary referral center. Oral Surgery Oral Medicine Oral Pathology Oral Radiology & Endodontics. 110(1):11-7, 2010 Jul.

Radiotherapy & Imaging

Bhide SA. Gulliford S. Fowler J. Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy. Radiotherapy & Oncology. 97(1):86-91, 2010 Oct.

Bussink J. van Herpen CM. Kaanders JH. PET-CT for response assessment and treatment adaptation in head and neck cancer. Lancet Oncology. 11(7):661-9, 2010 Jul.

Chera BS. Amdur RJ. Morris CG. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 78(2):461-6, 2010 Oct 1.

Glastonbury CM. Parker EE. Hoang JK. The postradiation neck: evaluating response to treatment and recognizing complications. AJR. American Journal of Roentgenology. 195(2):W164-71, 2010 Aug.

Goguen LA. Chapuy CI. Sher DJ. Utilizing computed tomography as a road map for designing selective and superselective neck dissection after chemoradiotherapy. Otolaryngology - Head & Neck Surgery. 143(3):367-74, 2010 Sep.

Houweling AC. van der Meer S. van der Wal E. Improved immobilization using an individual head support in head and neck cancer patients. Radiotherapy & Oncology. 96(1):100-3, 2010 Jul.

Rosenberg TL. Brown JJ. Jefferson GD. Evaluating the adult patient with a neck mass. Medical Clinics of North America. 94(5):1017-29, 2010 Sep.

Supportive Care & Symptom Management

Bensadoun RJ. Riesenbeck D. Lockhart PB. A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Supportive Care in Cancer. 18(8):1033-8, 2010 Aug.

Elad S. Zadik Y. Hewson I. A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea. Supportive Care in Cancer. 18(8):993-1006, 2010 Aug.

Epstein JB. Hong C. Logan RM. A systematic review of orofacial pain in patients receiving cancer therapy. Supportive Care in Cancer. 18(8):1023-31, 2010 Aug.

Gluck I. Feng FY. Lyden T. Evaluating and reporting dysphagia in trials of chemoirradiation for head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics. 77(3):727-33, 2010 Jul 1.

van Herpen CM. Mauer ME. Mesia R. Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323). British Journal of Cancer. 103(8):1173-81, 2010 Oct 12.

Jensen SB. Pedersen AM. Vissink A. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Supportive Care in Cancer. 18(8):1039-60, 2010 Aug.

Koiwai K. Shikama N. Sasaki S. Validation of the Total Dysphagia Risk Score (TDRS) as a predictive measure for acute swallowing dysfunction induced by chemoradiotherapy for head and neck cancers. Radiotherapy & Oncology. 97(1):132-5, 2010 Oct.

Lalla RV. Latortue MC. Hong CH. A systematic review of oral fungal infections in patients receiving cancer therapy. Supportive Care in Cancer. 18(8):985-92, 2010 Aug.

Lin YS. Lin LC. Lin SW. Discrepancy of the effects of zinc supplementation on the prevention of radiotherapy-induced mucositis between patients with nasopharyngeal carcinoma and those with oral cancers: subgroup analysis of a double-blind, randomized study. Nutrition & Cancer. 62(5):682-91, 2010 Jul.

Roe JW. Carding PN. Dwivedi RC. Swallowing outcomes following Intensity Modulated Radiation Therapy (IMRT) for head & neck cancer - a systematic review. Oral Oncology. 46(10):727-33, 2010 Oct.

Rogers SN. Forgie S. Lowe D. Development of the International Classification of Functioning, Disability and Health as a brief head and neck cancer patient questionnaire. International Journal of Oral & Maxillofacial Surgery. 39(10):975-82, 2010 Oct.

Shaffer BT. Cohen MS. Bigelow DC. Validation of a disease-specific quality-of-life instrument for acoustic neuroma: the Penn Acoustic Neuroma Quality-of-Life Scale. Laryngoscope. 120(8):1646-54, 2010 Aug.

Spiegelberg L. Djasim UM. van Neck HW. Hyperbaric oxygen therapy in the management of radiation-induced injury in the head and neck region: a review of the literature. Journal of Oral & Maxillofacial Surgery. 68(8):1732-9, 2010 Aug.

Watanabe T. Ishihara M. Matsuura K. Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer. International Journal of Cancer. 127(8):1984-90, 2010 Oct 15.

Wu SX. Cui TT. Zhao C. A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma. Radiotherapy & Oncology. 97(1):113-8, 2010 Oct.

Surgery

Garg A. Dwivedi RC. Sayed S. Robotic surgery in head and neck cancer: a review. Oral Oncology. 46(8):571-6, 2010 Aug

Karatzanis AD. Psychogios G. Waldfahrer F. T1 and T2 hypopharyngeal cancer treatment with laser microsurgery. Journal of Surgical Oncology. 102(1):27-33, 2010 Jul 1.

Moolenburgh SE. McLennan L. Levendag PC. Nasal reconstruction after malignant tumor resection: an algorithm for treatment. Plastic & Reconstructive Surgery. 126(1):97-105, 2010 Jul.

Mardini S. Salgado CJ. Kim Evans KF. Reconstruction of the esophagus and voice. Plastic & Reconstructive Surgery. 126(2):471-85, 2010 Aug.

Rameh C. Magnan J. Quality of life of patients following stages III-IV vestibular schwannoma surgery using the retrosigmoid and translabyrinthine approaches. Auris, Nasus, Larynx. 37(5):546-52, 2010 Oct.

Please note that the journal articles you are accessing may be protected by copyright legislation so there may be a limit on the number of articles you can download or print from any single issue of a journal.  If you obtain a copy via your local library's document request service, you may be required to complete a copyright declaration form.  Consult your local library with any queries, or for further information see the website of the Copyright Licensing Agency at cla.co.uk.

If you have any questions regarding this or any other library services please contact Library staff – contact details are at the beginning of the bulletin.

Sources used for this bulletin :

OVID MEDLINE and MEDLINE in process, local journal collection

-----------------------

Head and Neck Cancer

October 2010

-----------------------

6

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download